Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Interest & Investment Income (2021 - 2022)

Historic Interest & Investment Income for Kiniksa Pharmaceuticals International (KNSA) over the last 2 years, with Q3 2022 value amounting to $322000.0.

  • Kiniksa Pharmaceuticals International's Interest & Investment Income rose 634000.0% to $322000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $536000.0, marking a year-over-year change of. This contributed to the annual value of $97000.0 for FY2021, which is 9144.62% down from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Interest & Investment Income stood at $322000.0 for Q3 2022, which was up 634000.0% from $103000.0 recorded in Q2 2022.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Interest & Investment Income peaked at $322000.0 during Q3 2022, and registered a low of $5000.0 during Q3 2021.